Cargando…
Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
OBJECTIVE: In Japan, pleurodesis is often performed using OK-432. However, OK-432 may cause severe chest pain and fever. The risk factors for these complications are unclear. The aim of this study was to identify the risk factors for chest pain and fever caused by pleurodesis with OK-432. METHODS: T...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047981/ https://www.ncbi.nlm.nih.gov/pubmed/29434153 http://dx.doi.org/10.2169/internalmedicine.9637-17 |
_version_ | 1783340018004131840 |
---|---|
author | Morimoto, Yoshihito Takei, Hidefumi Tachibana, Keisei Nakazato, Yoko Tanaka, Ryota Nagashima, Yasushi Watanabe, Kazuhiro Seki, Reisuke Shinohara, Takao Kondo, Haruhiko |
author_facet | Morimoto, Yoshihito Takei, Hidefumi Tachibana, Keisei Nakazato, Yoko Tanaka, Ryota Nagashima, Yasushi Watanabe, Kazuhiro Seki, Reisuke Shinohara, Takao Kondo, Haruhiko |
author_sort | Morimoto, Yoshihito |
collection | PubMed |
description | OBJECTIVE: In Japan, pleurodesis is often performed using OK-432. However, OK-432 may cause severe chest pain and fever. The risk factors for these complications are unclear. The aim of this study was to identify the risk factors for chest pain and fever caused by pleurodesis with OK-432. METHODS: The clinical data of 94 patients who underwent pleurodesis with OK-432 were retrospectively analyzed. Patients who developed chest pain (indicated by a record of rescue pain medication) and/or fever (a recorded temperature of >38℃) were identified. A logistic regression analysis was performed to determine the risk factors for these complications. RESULTS: Rescue medication for chest pain was required by 43.6% of the patients and 40.4% developed pyrexia after pleurodesis with OK-432. The univariate analysis showed that the likelihood of requiring rescue medication for chest pain was significantly increased in patients of <70 years of age (p=0.028) and in those who were not premedicated with a nonsteroidal anti-inflammatory drug (NSAID; p=0.003). Age <70 years (adjusted odds ratio 2.97, 95% confidence interval 1.10-8.00, p=0.031) and a lack of premedication with an NSAID (adjusted odds ratio 4.21, 95% confidence interval 1.47-12.04, p=0.007) remained significant factors in a multivariate analysis. The absence of NSAID premedication was the only statistically significant risk factor for fever in the univariate analysis (p=0.034). The multivariate analysis revealed no significant risk factors for fever. CONCLUSION: The results of the present study suggest that premedication with an NSAID might be useful for preventing the chest pain caused by pleurodesis with OK-432. Furthermore, caution is advised when managing chest pain in adults of <70 years of age. Prospective studies should be performed to further investigate this issue. |
format | Online Article Text |
id | pubmed-6047981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-60479812018-07-17 Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 Morimoto, Yoshihito Takei, Hidefumi Tachibana, Keisei Nakazato, Yoko Tanaka, Ryota Nagashima, Yasushi Watanabe, Kazuhiro Seki, Reisuke Shinohara, Takao Kondo, Haruhiko Intern Med Original Article OBJECTIVE: In Japan, pleurodesis is often performed using OK-432. However, OK-432 may cause severe chest pain and fever. The risk factors for these complications are unclear. The aim of this study was to identify the risk factors for chest pain and fever caused by pleurodesis with OK-432. METHODS: The clinical data of 94 patients who underwent pleurodesis with OK-432 were retrospectively analyzed. Patients who developed chest pain (indicated by a record of rescue pain medication) and/or fever (a recorded temperature of >38℃) were identified. A logistic regression analysis was performed to determine the risk factors for these complications. RESULTS: Rescue medication for chest pain was required by 43.6% of the patients and 40.4% developed pyrexia after pleurodesis with OK-432. The univariate analysis showed that the likelihood of requiring rescue medication for chest pain was significantly increased in patients of <70 years of age (p=0.028) and in those who were not premedicated with a nonsteroidal anti-inflammatory drug (NSAID; p=0.003). Age <70 years (adjusted odds ratio 2.97, 95% confidence interval 1.10-8.00, p=0.031) and a lack of premedication with an NSAID (adjusted odds ratio 4.21, 95% confidence interval 1.47-12.04, p=0.007) remained significant factors in a multivariate analysis. The absence of NSAID premedication was the only statistically significant risk factor for fever in the univariate analysis (p=0.034). The multivariate analysis revealed no significant risk factors for fever. CONCLUSION: The results of the present study suggest that premedication with an NSAID might be useful for preventing the chest pain caused by pleurodesis with OK-432. Furthermore, caution is advised when managing chest pain in adults of <70 years of age. Prospective studies should be performed to further investigate this issue. The Japanese Society of Internal Medicine 2018-02-09 2018-06-15 /pmc/articles/PMC6047981/ /pubmed/29434153 http://dx.doi.org/10.2169/internalmedicine.9637-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Morimoto, Yoshihito Takei, Hidefumi Tachibana, Keisei Nakazato, Yoko Tanaka, Ryota Nagashima, Yasushi Watanabe, Kazuhiro Seki, Reisuke Shinohara, Takao Kondo, Haruhiko Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 |
title | Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 |
title_full | Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 |
title_fullStr | Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 |
title_full_unstemmed | Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 |
title_short | Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 |
title_sort | risk factors for chest pain and fever in patients undergoing pleurodesis with ok-432 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047981/ https://www.ncbi.nlm.nih.gov/pubmed/29434153 http://dx.doi.org/10.2169/internalmedicine.9637-17 |
work_keys_str_mv | AT morimotoyoshihito riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT takeihidefumi riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT tachibanakeisei riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT nakazatoyoko riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT tanakaryota riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT nagashimayasushi riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT watanabekazuhiro riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT sekireisuke riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT shinoharatakao riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 AT kondoharuhiko riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432 |